CLINICAL IMPORTANCE OF PHARMACOKINETIC AND PHARMACODYNAMIC DRUG INTERACTIONS.KOCH WESER J.1977; NETHERL. J. MED.; NETHERL.; DA. 1977; VOL. 20; NO 2; PP. 59-70; BIBL. 1 P. 1/2Article

DRUG THERAPY: METOPROLOLKOCH WESER J.1979; NEW ENGL. J. MED.; USA; DA. 1979; VOL. 301; NO 13; PP. 698-703; BIBL. 66 REF.Article

SERUM PROCAINAMIDE LEVELS AS THERAPEUTIC GUIDES.KOCH WESER J.1977; CLIN. PHARMACOKINET.; NETHERL.; DA. 1977; VOL. 2; NO 6; PP. 389-402; BIBL. 3 P.Article

DRUG THERAPY: HYDRALAZINE.KOCH WESER J.1976; NEW ENGL. J. MED.; U.S.A.; DA. 1976; VOL. 295; NO 6; PP. 320-323; BIBL. 33 REF.Article

MEDIKAMENTOESE WECHSELWIRKUNGEN IN DER KARDIOVASKULAEREN THERAPIE. = INTERACTIONS MEDICAMENTEUSES DANS LE TRAITEMENT CARDIOVASCULAIREKOCH WESER J.1976; SCHWEIZ. MED. WSCHR.; SCHWEIZ.; DA. 1976; VOL. 106; NO 45; PP. 1531-1538; ABS. ANGL.; BIBL. 21 REF.Article

DRUG INTERACTIONS IN CARDIOVASCULAR THERAPY. = INTERACTIONS DES MEDICAMENTS EN THERAPEUTIQUE CARDIO-VASCULAIREKOCH WESER J.1975; AMER. HEART J.; U.S.A.; DA. 1975; VOL. 90; NO 1; PP. 93-116; BIBL. 6 P.Article

THE SERUM LEVEL APPROACH TO INDIVIDUALIZATION OF DRUG DOSAGE.KOCH WESER J.1975; EUROP. J. CLIN. PHARMACOL.; GERM.; DA. 1975; VOL. 9; NO 1; PP. 1-8; BIBL. 35 REF.Article

DRUG THERAPY. BIOVAILABILITY OF DRUGS (FIRST OF TWO PARTS) = TRAITEMENT MEDICAMENTEUX. BIOEFFICACITE DES MEDICAMENTS (1RE PARTIE)KOCH WESER J.1974; NEW ENGL. J. MED.; U.S.A.; DA. 1974; VOL. 291; NO 5; PP. 233-237; BIBL. 22REF.Article

INDIVIDUALIZATION OF ANTIHYPERTENSIVE DRUG THERAPY = INDIVIDUALISATION DU TRAITEMENT PAR LES HYPOTENSEURSKOCH WESER J.1974; MED. CLIN. N. AMER.; U.S.A.; DA. 1974; VOL. 58; NO 5; PP. 1027-1036; BIBL. 33REF.Article

DRUG THERAPY: ANTIVIRAL AGENTS. IKOCH WESER J.1980; NEW ENGL. J. MED.; USA; DA. 1980; VOL. 302; NO 16; PP. 903-907; BIBL. 56 REF.Article

DRUG THERAPY: DISOPYRAMIDEKOCH WESER J.1979; NEW ENGL. J. MED.; USA; DA. 1979; VOL. 300; NO 17; PP. 957-962; BIBL. 59 REF.Article

VASODILATOR DRUGS IN THE TREATMENT OF HYPERTENSION = VASODILATATEURS DANS LE TRAITEMENT DE L'HYPERTENSIONKOCH WESER J.1974; ARCH. INTERN. MED.; U.S.A.; DA. 1974; VOL. 133; NO 6; PP. 1017-1027; BIBL. 2P.1/2Article

DRUG THERAPY: DIAZOXIDEKOCH WESER J.1976; NEW ENGL. J. MED.; U.S.A.; DA. 1976; VOL. 294; NO 23; PP. 1271-1274; BIBL. 41 REF.Article

DRUG THERAPY. SERUM DRUG CONCENTRATIONS AS THERAPEUTIC GUIDESKOCH WESER J.1972; NEW ENGL. J. MED.; U.S.A.; DA. 1972; VOL. 287; NO 5; PP. 227-231; BIBL. 15 REF.Serial Issue

EFFECTS OF ALPHA -DIFLUOROMETHYLORNITHINE ALONE AND COMBINED WITH ADRIAMYCIN OR VINDESINE ON L1210 LEUKEMIA IN MICE, EMT6 SOLID TUMORS IN MICE, AND SOLID TUMORS INDUCED BY INJECTION OF HEPATOMA TISSUE CULTURE CELLS IN RATSBARTHOLEYNS J; KOCH WESER J.1981; CANCER RES.; ISSN 0008-5472; USA; DA. 1981; VOL. 41; NO 12; PART. 1; PP. 5158-5161; BIBL. 15 REF.Article

DRUG INTERACTIONS IN CLINICAL PERSPECTIVE.KOCH WESER J; GREENBLATT DJ.1977; EUROP. J. CLIN. PHARMACOL.; GERM.; DA. 1977; VOL. 11; NO 6; PP. 405-408; BIBL. 32 REF.Article

DRUG THERAPY. BINDING OF DRUGS TO SERUM ALBUMIN. I = CHIMIOTHERAPIE. LA LIAISON DES MEDICAMENTS A LA SERUMALBUMINEKOCH WESER J; SELLERS EM.1976; NEW ENGL. J. MED.; U.S.A.; DA. 1976; VOL. 294; NO 6; PP. 311-316; BIBL. 29 REF.Article

DRUG THERAPY: CLINICAL PHARMACOKINETICS. II. = TRAITEMENT MEDICAMENTEUX. PHARMACOCINETIQUE CLINIQUE. IIGREENBLATT DJ; KOCH WESER J.1975; NEW ENGL. J. MED.; U.S.A.; DA. 1975; VOL. 293; NO 19; PP. 964-970; BIBL. 48 REF.Article

CLINICAL TOXICITY OF CHLORDIAZEPOXIDE AND DIAZEPAM IN RELATION TO SERUM ALBUMIN CONCENTRATION: A REPORT FROM THE BOSTON COLLABORATIVE DRUG SURVEILLANCE PROGRAM = LA TOXICITE CLINIQUE DU CHLORDIAZEPOXIDE ET DU DIAZEPAM EN RAPPORT AVEC LA CONCENTRATION DE L'ALBUMINE SERIQUE: RAPPORT DU PROGRAMME EN COLLABORATION D'ETUDE DES MEDICAMENTS DE BOSTONGREENBLATT DJ; KOCH WESER J.1974; EUROP. J. CLIN. PHARMACOL.; GERM.; DA. 1974; VOL. 7; NO 4; PP. 259-262; BIBL. 15REF.Article

HOW DANGEROUS IN PROPRANOLOL. = QUEL EST LE DANGER DU PROPRANOLOL.ERIKSSEN J; GREENBLATT DJ; KOCH WESER J et al.1974; AMER. HEART J.; U.S.A.; DA. 1974; VOL. 88; NO 3; PP. 391; BIBL. 2REF.Article

EVIDENCE FOR SYSTEMATIC TEMPORAL IN 24-HOUR URINARY CREATININE EXCRETION.RANSIL BJ; GREENBLATT DJ; KOCH WESER J et al.1977; J. CLIN. PHARMACOL.; U.S.A.; DA. 1977; VOL. 17; NO 2-3; PP. 108-119; BIBL. 5 REF.Article

BIOAVAILABILITY OF DRUGS: THE DIGOXIN DILEMMAGREENBLATT DJ; SMITH TW; KOCH WESER J et al.1976; CLIN. PHARMACOKINET.; NETHERL.; DA. 1976; VOL. 1; NO 1; PP. 36-51; BIBL. 4 P.Article

IMPORTANCE OF PROTEIN BINDING FOR THE INTERPRETATION OF SERUM OR PLASMA DRUG CONCENTRATIONSGREENBLATT DJ; SELLERS EM; KOCH WESER J et al.1982; J. CLIN. PHARMACOL.; ISSN 0091-2700; USA; DA. 1982; VOL. 22; NO 5/6; PP. 259-263; BIBL. 17 REF.Article

CLINICAL USE AND TOXICITY OF INTRAVENOUS LIDOCAINE. A REPORT FROM THE BOSTON COLLABORATIVE DRUG SURVEILLANCE PROGRAM.PFEIFER HJ; GREENBLATT DJ; KOCH WESER J et al.1976; AMER. HEART J.; U.S.A.; DA. 1976; VOL. 92; NO 2; PP. 168-173; BIBL. 25 REF.Article

SERUM CREATINE PHOSPHOKINASE CONCENTRATIONS AFTER INTRAMUSCULAR CHLORDIAZEPOXIDE AND ITS SOLVENT.GREENBLATT DJ; SHADER RJ; KOCH WESER J et al.1976; J. CLIN. PHARMACOL.; U.S.A.; DA. 1976; VOL. 16; NO 2-3; PP. 118-121; BIBL. 1 P. 1/2Article